Jaguar Health entered into two exchange agreements with Streeterville Capital on May 21, 2026. The company issued a total of 54,222 shares of common stock in exchange for 7.96 shares of Series Q Perpetual Preferred Stock. The exchanged preferred shares were cancelled and retired upon completion of the transactions. The 2026 Annual Meeting of Stockholders, originally scheduled for May 22, 2026, was adjourned until June 2, 2026. The meeting adjournment is intended to allow the company to provide additional information to stockholders regarding proposals in the proxy statement.